Metraipolis › archive › dc_efac668f5e6e

Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122 — Europe PMC PMID:41631899

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41631899
DOI
10.1002/cam4.71496
License (as archived)
solo-consultazione
Archived
2026-11-06T08:47:26.679Z
SHA-256 of the archived text
9056a142da12affa1231bf60b7fc32839ea274bef7f6156696c4a0cf9fb3593b
Stable URL of this page
https://metraipolis.com/documento/dc_efac668f5e6e

How to cite

Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122 — Europe PMC PMID:41631899 — Europe PMC (en), https://europepmc.org/article/MED/41631899 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_efac668f5e6e (Metraipolis archive dc_efac668f5e6e, sha256 9056a142da12affa1231bf60b7fc32839ea274bef7f6156696c4a0cf9fb3593b)
BibTeX
@misc{dcefac668f5e6e,
  title = {Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122 — Europe PMC PMID:41631899},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41631899},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_efac668f5e6e; sha256 9056a142da12affa1231bf60b7fc32839ea274bef7f6156696c4a0cf9fb3593b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41631899. Agents can read the archived copy with the MCP tool read_document.